A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery

Authors: Rosenbaum, Evan, Chugh, Rashmi, Ryan, Christopher W., Agulnik, Mark, Milhem, Mohammed M., George, Suzanne, Jones, Robin L., Chmielowski, Bartosz, Van Tine, Brian A., Tawbi, Hussein, Elias, Anthony D., Read, William L., Budd, G. Thomas, Qin, Li-Xuan, Rodler, Eve T., Hirman, Joe, Weiden, Paul, Bennett, Cathryn M., Livingston, Philip O., Ragupathi, Govind, Hansen, David, D'Angelo, Sandra P., Tap, William D., Schwartz, Gary K., Maki, Robert G., Carvajal, Richard D.

Source: In European Journal of Cancer November 2022 176:155-163

Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.

Authors: Smith, Karen L., Fengmin Zhao, Mayer, Ingrid A., Tevaarwerk, Amye J., Garcia, Sofia F., Arteaga, Carlos L., Symmans, William F., Park, Ben H., Burnette, Brian L., Makower, Della F., Block, Margaret, Morley, Kimberly A., Jani, Chirag R., Mescher, Craig, Dewani, Shabana J., Brown-Glaberman, Ursa, Flaum, Lisa E., Mayer, Erica L., Sikov, William M., Rodler, Eve T.

Source: Cancer (0008543X); 5/15/2024, Vol. 130 Issue 10, p1447-1757, 11p

Subject Terms: TRIPLE-negative breast cancer, PATIENT reported outcome measures, PATIENT experience, PATIENTS' attitudes, PLATINUM

Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung.

Authors: Baird, Kristin¹, Glod, John², Steinberg, Seth M.³, Reinke, Denise⁴, Pressey, Joseph G.⁵, Mascarenhas, Leo⁶, Federman, Noah⁷, Marina, Neyssa⁸, Chawla, Sant⁹, Lagmay, Joanne P.¹⁰, Goldberg, John¹¹, Milhem, Mohammed¹², Loeb, David M.¹³, Butrynski, James E.¹⁴, Turpin, Brian¹⁵, Staddon, Arthur¹⁶, Spunt, Sheri L.¹⁷, Jones, Robin L.¹⁸, Rodler, Eve T.¹⁹, Schuetze, Scott M.²⁰

Source: Sarcoma; 5/1/2020, p1-6, 6p, 1 Diagram, 1 Chart, 2 Graphs

A randomized phase III post-operative trial of platinum-based chemotherapy (P) versus capecitabine (C) in patients (pts) with residual triple-negative breast cancer (TNBC) following neoadjuvant chemotherapy (NAC): ECOG-ACRIN EA1131

Authors: Mayer, Ingrid A., Zhao, Fengmin, Arteaga, Carlos L., Symmans, William Fraser, Park, Ben Ho, Burnette, Brian Leslie, Tevaarwerk, Amye Juliet, Garcia, Sofia F., Smith, Karen L., Mayer, Erica L., Sikov, William M., Rodler, Eve T., Wagner, Lynne I., DeMichele, Angela, Sparano, Joseph A., Wolff, Antonio C., Miller, Kathy

Source: Journal of clinical oncology. 39(15 suppl):605-605

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173176139.0x000001&indx=1&recIds=ETOCvdc_100173176139.0x000001

Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.

Authors: Mayer, Ingrid A, Zhao, Fengmin, Arteaga, Carlos L, Symmans, William F, Park, Ben H, Burnette, Brian L, Tevaarwerk, Amye J, Garcia, Sofia F, Smith, Karen L, Makower, Della F, Block, Margaret, Morley, Kimberly A, Jani, Chirag R, Mescher, Craig, Dewani, Shabana J, Tawfik, Bernard, Flaum, Lisa E, Mayer, Erica L, Sikov, William M, Rodler, Eve T

Source: Journal of Clinical Oncology; 8/10/2021, Vol. 39 Issue 23, p2539-2551, 13p

This result is not displayed to guests.
Login for full access.

Systemic therapy in primary angiosarcoma of the spleen.

Authors: Ferreira, Bruna Pellini¹, Rodler, Eve T.^2,3, Loggers, Elizabeth T.^2,3,4, Pollack, Seth M.^2,3, Jones, Robin L.^2,3 rjones@seattlecca.org

Source: Rare Tumors. 2012, Vol. 4 Issue 4, p178-180. 3p.

Subject Terms: *ANGIOSARCOMA, *SPLEEN diseases, *TUMORS, *SPLENECTOMY, *DOXORUBICIN

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.